CASI Pharmaceuticals (CASIF) EBT Margin (2022 - 2025)
CASI Pharmaceuticals (CASIF) recorded EBT Margin of -1068.82% in Q4 2025, down 973.10 percentage points from -95.72% a year earlier and down 721.92 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) EBT Margin (2022 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals reported EBT Margin of -221.47%, down 88.07 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +92.32 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -133.40% in FY2024 (-55.80 pp), -77.61% in FY2023 (+9.23 pp), -86.83% in FY2022 (+31.98 pp) and -118.81% in FY2021 (+194.98 pp).
- The Q4 2025 figure is the lowest quarterly EBT Margin in data going back to Q1 2022.
- On a year-over-year basis, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of -194.64 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 108.39 percentage points in Q1 2025, against a drop of 973.10 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -346.89% (Q3 2025), -265.39% (Q2 2025) and -165.10% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | CASI Pharmaceuticals | 1.86 Mn | -18.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1,068.82% |
| Sep 30, 2025 | -346.89% |
| Jun 30, 2025 | -265.39% |
| Mar 31, 2025 | -165.10% |
| Dec 31, 2024 | -95.72% |
| Sep 30, 2024 | -106.78% |
| Jun 30, 2024 | -217.49% |
| Mar 31, 2024 | -273.48% |
| Dec 31, 2023 | -49.85% |
| Sep 30, 2023 | -57.65% |
| Jun 30, 2023 | -95.16% |
| Mar 31, 2023 | -86.41% |
| Dec 31, 2022 | -97.70% |
| Sep 30, 2022 | -55.98% |
| Jun 30, 2022 | -74.75% |
| Mar 31, 2022 | -77.09% |
API Access
CASI Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();